17:13:32 EDT Tue 15 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:GCTK - GLUCOTRACK INC - https://glucotrack.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
GCTK - Q1.05.34·5.730.15.45-0.20-3.5235.11,3011,2225.65  6.14  5.293,755.9937  5.1816:46:36Jul 0815 min RT 2¢

Recent Trades - Last 10 of 1222
Time ETExPriceChangeVolume
16:46:36Q5.45-0.201
16:32:11Q5.5596-0.090482
16:22:13Q5.56-0.091
16:15:05Q5.35-0.301
16:13:16Q5.36-0.29204
16:11:56Q5.36-0.29488
16:10:33Q5.36-0.2910
16:00:06Q5.45-0.2063
16:00:01Q5.45-0.2054
16:00:01Q5.45-0.20511

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-08 08:30U:GCTKNews ReleaseGlucotrack Announces Repurchase of Series A Warrants
2025-06-25 08:30U:GCTKNews ReleaseGlucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions
2025-06-12 09:05U:GCTKNews ReleaseGlucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
2025-06-04 08:30U:GCTKNews ReleaseGlucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions
2025-05-28 08:30U:GCTKNews ReleaseGlucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
2025-05-20 08:30U:GCTKNews ReleaseGlucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development
2025-05-14 17:10U:GCTKNews ReleaseGlucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-13 08:01U:GCTKNews ReleaseGlucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
2025-04-16 08:00U:GCTKNews ReleaseGlucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
2025-04-03 08:01U:GCTKNews ReleaseGlucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
2025-03-31 17:00U:GCTKNews ReleaseGlucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
2025-03-19 08:01U:GCTKNews ReleaseGlucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes
2025-02-26 08:01U:GCTKNews ReleaseGlucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
2025-02-04 12:25U:GCTKNews ReleaseGlucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
2025-02-04 08:01U:GCTKNews ReleaseGlucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
2025-01-30 08:00U:GCTKNews ReleaseGlucotrack Announces Reverse Stock Split
2025-01-29 09:00U:GCTKNews ReleaseGlucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
2025-01-21 08:01U:GCTKNews ReleaseGlucotrack Announces ISO 13485:2016 Certification
2025-01-15 08:01U:GCTKNews ReleaseGlucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs
2025-01-07 16:05U:GCTKNews ReleaseGlucotrack to Present at TechBio Showcase(TM) 2025